Platinum Investment Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Platinum Investment Management's CLB Position: Q1 2026 in Review
Platinum Investment Management sold out of Core Laboratories (CLB) in Q1 2026, closing a stake of 4,196 shares — an estimated $67.3K sold.
Platinum Investment Management first reported a position in CLB in Q1 2022 and held it in 16 quarters. The position peaked at $300K in Q1 2025. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Platinum Investment Management reported no remaining Core Laboratories position as of Q1 2026 after selling out during the quarter.
- Platinum Investment Management sold 4,196 Core Laboratories shares in Q1 2026, an estimated $67.3K.
- Platinum Investment Management first reported a position in Core Laboratories in Q1 2022 and held it in 16 quarters.
- Platinum Investment Management's Core Laboratories position peaked at $300K in Q1 2025.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Platinum Investment Management's 13F filing for Q1 2026, filed 14 May 2026.